The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650. Issue 32 (6th July 2020)

• Record Type: Journal Article
• Authors: Su, Qiu-dong; Yi, Yao; Zou, Ye-ning; Jia, Zhi-yuan; Qiu, Feng; Wang, Feng; Yin, Wen-jiao; Zhou, Wen-ting; Zhang, Shuang; Yu, Peng-cheng; Bi, Sheng-li; Shen, Li-ping; Wu, Gui-zhen
• Is Part Of: Vaccine. Volume 38:Issue 32(2020)
• Page Start: 5071
• Page End: 5075
• Publication Date: 2020-07-06
• Subjects: Biological characteristics -- Spike protein Pro330-Leu650 -- SARS-CoV-2; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.04.070
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: The SARS-CoV-2-SPL possesses RBD and important B and T cell epitopes. The SARS-CoV-2-SPL has perfect topology structure with RBM as the head, RBD as the trunk and tail region. The successful preparation of SARS-CoV-SPL provides meaningful guide for the development of SARS-CoV-2 vaccine. Abstract: SARS-CoV-2 is the cause of the worldwide outbreak of COVID-19 that has been characterized as a pandemic by the WHO. Since the first report of COVID-19 on December 31, 2019, 179, 111 cases were confirmed in 160 countries/regions with 7426 deaths as of March 17, 2020. However, there have been no vaccines approved in the world to date. In this study, we analyzed the biological characteristics of the SARS-CoV-2 Spike protein, Pro330-Leu650 (SARS-CoV-2-SPL), using biostatistical methods. SARS-CoV-2-SPL possesses a receptor-binding region (RBD) and important B (Ser438-Gln506, Thr553-Glu583, Gly404-Aps427, Thr345-Ala352, and Lys529-Lys535) and T (9 CD4 and 11 CD8 T cell antigenic determinants) cell epitopes. High homology in this region between SARS-CoV-2 and SARS-CoV amounted to 87.7%, after taking the biological similarity of the amino acids into account and eliminating the receptor-binding motif (RBM). The overall topology indicated that the complete structure of SARS-CoV-2-SPL was with RBM as the head, and RBD as the trunk and the tail region. SARS-CoV-2-SPL was found to have the potential to elicit effective B and T cell responses. Our findings may provide meaningful guidance for SARS-CoV-2 vaccine design.